Lam Research Corporation $LRCX Stock Position Decreased by Van ECK Associates Corp
Van ECK Associates Corp significantly reduced its stake in Lam Research Corporation (NASDAQ:LRCX) by 40.5% in the fourth quarter, selling over 1.8 million shares. Despite this large reduction by one institutional investor, other firms like Brighton Jones LLC and Osterweis Capital Management Inc. have substantially increased their holdings. Analysts maintain a "Moderate Buy" consensus rating for LRCX, with several issuing price target increases due to optimism surrounding AI-driven chip investment and strong financial performance.
Storgate LLC Acquires Shares of 9,673 Merck & Co., Inc. $MRK
Storgate LLC initiated a new position in Merck & Co., Inc. during the fourth quarter, purchasing 9,673 shares valued at approximately $1.0 million, making it their 13th largest holding. Other institutional investors like Brighton Jones, Diversify Advisory Services, and MIRAE ASSET GLOBAL ETFS also increased their stakes, leading to 76.07% institutional ownership of the stock. Merck recently reported strong first-quarter earnings and announced a quarterly dividend, with analysts maintaining a "Moderate Buy" consensus rating and an average price target of $128.18.
Dynamic Technology Lab Private Ltd Invests $2.07 Million in Sunrun Inc. $RUN
Dynamic Technology Lab Private Ltd has initiated a new position in Sunrun Inc. (NASDAQ:RUN), acquiring 112,728 shares valued at approximately $2.07 million in the fourth quarter. This investment represents about 0.5% of the fund's portfolio, making Sunrun its 20th largest holding. Despite Sunrun reporting strong quarterly earnings that exceeded expectations, the company faces cautious analyst ratings and notable insider selling.
Macquarie Group Ltd. Lowers Stock Position in CVS Health Corporation $CVS
Macquarie Group Ltd. reduced its stake in CVS Health Corporation by 10.1% in the fourth quarter of 2025, selling over 152,000 shares but still holding 1.36 million shares valued at about $107.5 million. This divestment occurred despite CVS Health's strong operational performance, including better-than-expected earnings and a raised FY2026 EPS guidance. While analyst sentiment is generally positive, significant insider selling, particularly by Director Larry Robbins and EVP Tilak Mandadi, has been noted.
Scansource stock hits 52-week high at $49.72 By Investing.com
ScanSource Inc. (SCSC) stock reached a 52-week high of $49.72, showing a year-to-date gain of nearly 27% and a 1-year change of 22.52%. The company is considered undervalued according to InvestingPro analysis, with a P/E ratio of 14.96 and a PEG ratio of 0.73. This strong performance follows outstanding third-quarter fiscal year 2026 results, where ScanSource exceeded both earnings and revenue forecasts.
Why SPX Technologies Stock’s Income Statement Tells a Different Story Than the Start-Up Cost Headlines in 2026
SPX Technologies (SPXC) exceeded Q1 2026 estimates, driven by a 17% year-over-year revenue increase and a significant acceleration in data center cooling demand, leading to raised full-year guidance. Despite temporary start-up costs impacting HVAC segment margins, the company demonstrates strong operating leverage and maintains a substantial operating margin advantage over competitors like Rexnord and Watts Water. TIKR's mid-case valuation suggests a 47% total return by December 2034, indicating the market may not yet fully price in the benefits of SPXC's capacity expansion and data center revenue ramp.
Clarkston Capital Partners LLC Lowers Stock Holdings in Keurig Dr Pepper, Inc $KDP
Clarkston Capital Partners LLC decreased its stake in Keurig Dr Pepper (NASDAQ:KDP) by 9.9% in the fourth quarter, selling 55,405 shares and retaining 505,970 shares valued at $14.17 million. Despite this reduction, institutional investors collectively own 93.99% of KDP shares. The company recently reported better-than-expected EPS of $0.39, declared a quarterly dividend of $0.23, and analysts currently rate the stock as a "Hold" with an average target price of $32.00.
Altria Group, Inc. $MO Shares Purchased by Macquarie Group Ltd.
Macquarie Group Ltd. increased its holdings in Altria Group (NYSE:MO) by 2.3% in the fourth quarter, bringing its total to 975,758 shares valued at $56.3 million. Altria reported strong quarterly results, exceeding EPS and revenue expectations and raising its FY 2026 guidance. The company also declared a quarterly dividend of $1.06 per share, offering an annualized yield of 5.9%.
Macquarie Group Ltd. Cuts Stake in Intuit Inc. $INTU
Macquarie Group Ltd. significantly reduced its stake in Intuit Inc. by 86.2% in the fourth quarter, selling over half a million shares and ending up with 85,530 shares valued at approximately $56.6 million. Despite this, Intuit reported strong quarterly results, exceeding EPS and revenue expectations, and announced a quarterly dividend. The company's stock, however, is trading near its 12-month low due to market sentiment and multiple analyst price target cuts, coupled with ongoing concerns about AI monetization and potential legal issues.
Macquarie Group Ltd. Lowers Holdings in American Express Company $AXP
Macquarie Group Ltd. significantly reduced its stake in American Express Company (AXP) by 79.6% in the fourth quarter, selling over 427,000 shares. Despite this, American Express reported strong Q4 earnings with $4.28 EPS, exceeding consensus estimates, and increased revenue by 11.4% year-over-year. The company also declared a quarterly dividend of $0.95 per share and provided positive FY 2026 EPS guidance, suggesting underlying strength despite some analysts maintaining a "Hold" rating.


